Physician profile
Steven Knott
NPI 1093315236
$2,256.34
in general payments reported to CMS, 2019-2025
14 companies · $85.13 in 2025
The $85.13 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $411 · 2022: $619 · 2023: $67.42 · 2024: $1,074 · 2025: $85.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,074 · Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,074.15 |
| Food and Beverage | $152.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $1,214.04 | 2022-2024 | Qelbree |
| Otsuka America Pharmaceutical, INC. | $261.03 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $140.78 | 2021-2025 | Trintellix |
| Abbvie INC. | $137.90 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $105.24 | 2021-2022 | |
| Alkermes, INC. | $84.08 | 2021-2022 | |
| Lundbeck LLC | $62.80 | 2021-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $54.20 | 2021-2022 | |
| Corium, LLC | $52.47 | 2022-2023 | Azstarys |
| Vanda Pharmaceuticals INC. | $51.48 | 2025 | Fanapt |
| Neuronetics, INC. | $32.24 | 2023 | Neurostar Tms Therapy System |
| Janssen Pharmaceuticals, INC | $32.15 | 2022 | |
| Ironshore Pharmaceuticals INC. | $15.50 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Knott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.